Benefit–Risk or Risk–Benefit Trade-Offs? Another Look at Attribute Ordering Effects in a Pilot Choice Experiment

被引：0
|
作者：
Sebastian Heidenreich
Andrea Phillips-Beyer
Bruno Flamion
Melissa Ross
Jaein Seo
Kevin Marsh
机构：
[1] Evidera Inc.,
[2] Innovus Consulting,undefined
[3] Idorsia Pharmaceuticals Ltd,undefined
来源：
The Patient - Patient-Centered Outcomes Research | 2021年 / 14卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：65 / 74
页数：9
相关论文
共 50 条
  • [1] Benefit-Risk or Risk-Benefit Trade-Offs? Another Look at Attribute Ordering Effects in a Pilot Choice Experiment
    Heidenreich, Sebastian
    Phillips-Beyer, Andrea
    Flamion, Bruno
    Ross, Melissa
    Seo, Jaein
    Marsh, Kevin
    PATIENT-PATIENT CENTERED OUTCOMES RESEARCH, 2021, 14 (01): : 65 - 74
  • [2] Benefit-Risk or Risk-Benefit Trade-offs? Another Look at Attribute Ordering Effects in DCEs
    Heidenreich, S.
    Beyer, A.
    Flamion, B.
    Ross, M.
    Seo, J.
    Marsh, K.
    PATIENT-PATIENT CENTERED OUTCOMES RESEARCH, 2019, 12 (04): : 433 - 433
  • [3] Risk-benefit trade-offs in revascularisation choices
    Federspiel, Jerome J.
    Stearns, Sally C.
    van Domburg, Ron T.
    Sheridan, Brett C.
    Lund, Jennifer L.
    Serruys, Patrick W.
    EUROINTERVENTION, 2011, 6 (08) : 936 - 941
  • [4] Evaluation of psoriasis patients' attitudes toward benefit-risk and therapeutic trade-offs in their choice of treatments
    Eliasson, Lina
    Bewley, Anthony P.
    Mughal, Farhan
    Johnston, Karissa M.
    Kuznik, Andreas
    Patel, Chloe
    Lloyd, Andrew J.
    PATIENT PREFERENCE AND ADHERENCE, 2017, 11 : 353 - 362
  • [5] CAREGIVERS' STATED AND REVEALED PREFERENCES FOR ANTIPSYCHOTIC MEDICATION USE AMONG YOUTH: A DISCRETE CHOICE EXPERIMENT OF BENEFIT-RISK TRADE-OFFS
    Fu, Y. H.
    Amill-Rosario, A.
    Dosreis, S.
    VALUE IN HEALTH, 2024, 27 (06) : S9 - S10
  • [6] Age, risk-benefit trade-offs, and the projected effects of evidence-based therapies
    Alter, DA
    Manuel, DG
    Gunraj, N
    Anderson, G
    Naylor, CD
    Laupacis, A
    AMERICAN JOURNAL OF MEDICINE, 2004, 116 (08): : 540 - 545
  • [7] Risk/benefit trade-offs in rheumatology: rofecoxib revisited in the era of JAK inhibitors
    Hazlewood, Glen S.
    RHEUMATOLOGY, 2023, 62 (12) : 3773 - 3775
  • [8] PERSONALIZING MEDICINE BY PATIENTS WILLINGNESS TO MAKE RISK-BENEFIT TRADE-OFFS
    Shih, V
    Bui, C. T.
    Gipson, G.
    Yan, S.
    Loucks, A.
    Miller, E.
    Waubant, E.
    Wilson, L. S.
    VALUE IN HEALTH, 2014, 17 (03) : A63 - A63
  • [9] What benefit-risk trade-offs are acceptable to rheumatoid arthritis patients during treatment selection? Evidence from a multicountry choice experiment
    Alten, Rieke
    Nieto-Gonzalez, Juan Carlos
    Jacques, Peggy
    Montecucco, Carlomaurizio
    Moots, Robert
    Radner, Helga
    Vonkeman, Harald E.
    Heidenreich, Sebastian
    Whichello, Chiara
    Krucien, Nicolas
    Van Beneden, Katrien
    RMD OPEN, 2024, 10 (01):
  • [10] Quantifying Benefit-Risk Trade-Offs Toward Prophylactic Treatment Among Adult Patients With Hemophilia A in China: Discrete Choice Experiment Study
    Wang, Limin
    Liu, Shimeng
    Jiang, Shan
    Li, Chaofan
    Lu, Liyong
    Fang, Yunhai
    Li, Shunping
    JMIR PUBLIC HEALTH AND SURVEILLANCE, 2023, 9
12345